DNTH
USDDianthus Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$33.890
Haut
$34.110
Bas
$32.960
Volume
0.43M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.3B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.69M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting
Positive data from Phase 2 MaGic trial presented for claseprubart in generalized Myasthenia Gravis, including new open-label extension data further supporting potential for 300mg/2mL Q4W dosing Phase 3 gMG trial planned
Truist Securities Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $56
Truist Securities analyst Danielle Brill initiates coverage on Dianthus Therapeutics with a Buy rating and announces Price Target of $56.
Actions Connexes
FBIOP
Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
AMD
Advanced Micro Devices Inc.
ATLCP
Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share
FRLA
Fortune Rise Acquisition Corporation
CORZZ
Core Scientific Inc. Tranche 2 Warrants
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.